Winter Respiratory Surge: Record 52% Positivity Rates & Key Vaccine Myths Debunked
- During Chile's winter holidays, respiratory virus positivity rates reached 52%, the highest of the year, according to El Mostrador.
- The 52% positivity rate, measured through diagnostic testing during the winter break, marks a peak not seen since the start of 2026, according to El Mostrador.
- Influenza B has emerged as the primary circulating virus, accounting for 68% of confirmed cases in the first half of June, according to the Observatorio de Enfermedades Infecciosas.
During Chile’s winter holidays, respiratory virus positivity rates reached 52%, the highest of the year, according to El Mostrador. The surge, reported amid increased travel and indoor gatherings, has prompted public health authorities to reinforce vaccination campaigns and caution against misinformation about influenza vaccines. The Observatorio de Enfermedades Infecciosas noted the figure represents a sharp rise from previous weeks, with influenza B strains dominating circulation, as reported by Publimetro.
The 52% positivity rate, measured through diagnostic testing during the winter break, marks a peak not seen since the start of 2026, according to El Mostrador. Health officials linked the spike to heightened community transmission, particularly in regions with school closures and family gatherings. BioBioChile cited regional health authorities in La Araucanía, where hospitalizations for respiratory illnesses have risen by 25% compared to the same period in 2025, underscoring the strain on healthcare systems.
What is driving the increase in respiratory virus cases?
Influenza B has emerged as the primary circulating virus, accounting for 68% of confirmed cases in the first half of June, according to the Observatorio de Enfermedades Infecciosas. Publimetro reported that La Araucanía, a region in southern Chile, has seen a 40% increase in outpatient visits for respiratory symptoms since mid-May. Health officials attributed the trend to seasonal factors, including colder temperatures and reduced ventilation in indoor spaces, combined with the relaxation of public health measures following the pandemic.
Dr. María González, a virologist at the Chilean Institute of Public Health, stated that influenza B tends to cause more severe symptoms in children and older adults, though it can affect all age groups. “The high positivity rate reflects both increased testing and actual transmission,” she said. “We are seeing a significant number of cases in schools and workplaces, which are typical settings for viral spread.”
How are health authorities responding to the surge?
Public health agencies have intensified vaccination drives, with SoyChile.cl reporting that over 70% of the population has received the seasonal influenza vaccine as of June 20. However, officials acknowledge gaps in coverage, particularly among younger adults and rural communities. The Ministry of Health launched a targeted campaign to address vaccine hesitancy, citing data from the Observatorio de Enfermedades Infecciosas that 32% of the population remains unvaccinated.
Authorities have also issued warnings about common misconceptions surrounding influenza vaccines. Publimetro highlighted a survey conducted by the Chilean Medical Association, which found that 45% of respondents believed the vaccine causes the flu, while 28% thought it was unnecessary for healthy individuals. “These myths are dangerous,” said Dr. Carlos Méndez, a public health official. “The influenza vaccine is safe and effective, and it is especially critical for reducing severe outcomes in high-risk groups.”
What are the broader implications for public health?
The current surge has raised concerns about potential overlaps with other respiratory viruses, such as respiratory syncytial virus (RSV) and rhinovirus, which typically circulate during colder months. The Observatorio de Enfermedades Infecciosas reported a 15% increase in RSV cases in June, though the overall impact remains lower than influenza. Health experts caution that co-infections could complicate treatment and worsen outcomes, particularly for immunocompromised individuals.
Comparing the 2026 surge to previous years, the Observatorio noted that the current positivity rate exceeds the 48% recorded during the 2023 winter peak. However, hospitalization rates remain below those seen in 2020-2021, attributed to higher vaccination coverage and improved treatments. “We are not seeing the same level of ICU admissions as before, which is a positive sign,” said Dr. González. “But we must remain vigilant to prevent a resurgence.”

As the winter season progresses, health authorities emphasize the importance of continued preventive measures, including mask-wearing in crowded spaces, hand hygiene, and seeking medical care for severe symptoms. SoyChile.cl reported that the Ministry of Health has allocated additional resources to regional hospitals in La Araucanía and other affected areas to manage the influx of patients.
For now, the focus remains on combating misinformation and ensuring equitable access to vaccines. With the 52% positivity rate serving as a stark reminder of the ongoing threat posed by respiratory viruses, public health officials urge the population to prioritize vaccination and adhere to
